Examkin

Question

Difficulty: MediumMonitoring and Treatment Evaluation

A 52-year-old woman is hospitalized for a massive pulmonary embolism and treated with a continuous unfractionated heparin infusion. On hospital day 66, her platelet count decreases from an admission baseline of 260,000/mm3260,000/\text{mm}^3 to 85,000/mm385,000/\text{mm}^3. She subsequently reports acute left lower extremity pain, and a duplex ultrasound confirms a new deep vein thrombosis. Her clinical presentation yields a 4T score indicating a high probability of heparin-induced thrombocytopenia (HIT). Arrange the following therapeutic management and monitoring steps in the correct chronological sequence.

  1. 1Discontinue all sources of unfractionated heparin.
  2. 2Initiate a direct thrombin inhibitor such as argatroban.
  3. 3Monitor daily platelet counts until recovery to ≥150,000/mm3\geq 150,000/\text{mm}^3.
  4. 4Initiate oral warfarin therapy.
  5. 5Discontinue the direct thrombin inhibitor once the INR is therapeutic for 4848 hours.

Answer

The correct sequence is to first discontinue heparin, immediately start a non-heparin anticoagulant (argatroban), monitor platelets until they recover above 150,000, then initiate warfarin, and finally stop argatroban after the INR has been therapeutic for 48 hours.
The management of HIT requires a strict multi-step de-escalation and transition protocol. All heparin must be stopped immediately to break the cycle of PF4-antibody complex formation. Because the patient is actively thrombosing, an alternative anticoagulant (e.g., argatroban, bivalirudin, or fondaparinux) must be started empirically without waiting for lab confirmation. The transition to long-term warfarin requires careful monitoring: platelets must first recover to baseline or ≥150,000/mm3\geq 150,000/\text{mm}^3 to avoid warfarin-induced skin necrosis and venous limb gangrene. Once started, warfarin must overlap with the parenteral anticoagulant for at least 55 days, and the parenteral agent is only discontinued when the INR has been therapeutic for 4848 hours.

Step-by-Step Solution

1
Discontinue heparin
Halts the ongoing formation of heparin-PF4 complexes.
Continuing heparin worsens the immune response and exacerbates thrombosis.
2
Initiate argatroban
Provides immediate, safe anticoagulation.
Patients with HIT are highly prothrombotic and require continuous anticoagulation while avoiding all heparin products.
3
Monitor platelet recovery
Confirms the HIT process is resolving.
Wait for platelets to reach at least 150,000/mm3150,000/\text{mm}^3 to ensure the hypercoagulable state is stabilizing.
4
Initiate warfarin
Begins the transition to long-term oral anticoagulation.
Starting warfarin too early (before platelet recovery) causes a precipitous drop in Protein C, paradoxically worsening hypercoagulability and risking venous limb gangrene.
5
Overlap and discontinue argatroban
Ensures uninterrupted protection against thrombosis.
Warfarin takes several days to achieve full antithrombotic effect. Argatroban must be continued until the INR is therapeutic (2.0−3.02.0-3.0) for at least 4848 hours.

Key Concept

Management and monitoring sequence of Heparin-Induced Thrombocytopenia (HIT)
Estimated Time:1m 30s
Rate this question

Topics

Monitoring and Treatment Evaluation

More questions from this topic